Home › Trial NCT06155422
A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer
- Trial IDNCT06155422
- StatusNot Yet Recruiting
- PhaseN/A
- Study typeObservational
- SponsorGang Chen (101199)
- Enrollment670
- Start date2023-11-30
- ConditionsRecurrent or Metastatic Cervical Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.